According to a story on the Huffington Post, Johnson & Johnson has lowered its planned bonuses for the company’s top executives by 10 percent.
A statement from the company acknowledges “disappointments” from 2012, and resultant damage to the company’s public reputation.
Johnson & Johnson’s annual proxy statement says, in part: “We worked to address several reputational challenges and continue to strive toward regaining the reputational standings that we expect of ourselves and ...
continue reading...
Health care giant Johnson & Johnson’s legal troubles are apparently giving investor Warren Buffett pause, according to a blog item for the Philadelphia Inquirer.
The plaintiff in the second trial over the DePuy Orthopaedics ASR hip implant is seeking punitive damages – indicating “fraud or malice” – as well as compensatory damages, according to Reuters.
Another trial involving a DePuy Orthopaedics hip implant is set to begin in Illinois, right on the heels of a Los Angeles trial that netted an $8.33 million settlement for the plaintiff, Reuters reports.
According to a story on Fox News, prosecutors in Greece have filed corruption charges against officials with DePuy Orthopedics, a subsidiary of Johnson & Johnson.
An opinion piece in the New York Times explores an issue that emerged in the course of a trial over DePuy Orthopaedics’ ASR hip implants – doctors who remain silent over harmful medical devices or drugs.
